Table 4 Clinical assessment resources which are in common use for ADHD
Rating scales | ||||
Assessment name [reference ID] | Age range (years) | Application | Female norms | Free access |
Conners’ Comprehensive Behavior Rating Scales (CBRS) [111] | 6-18 | • Patient-rated (age 8-18) • Parent rated • Teacher rated | Yes | No |
SNAP-IV R Rating Scale [112] | 8-18 | • Parent rated • Teacher rated | No | Yes |
RATE-C [113] | 8-11 | • Patient-rated • Informant rated | No | Yes |
6-18 | • Patient rated • Parent rated | No | Yes | |
Strengths and Difficulties Questionnaire (SDQ) [116] | 3-16 | • Patient-rated (age 11-16) • Parent rated • Teacher rated | Yes | Yes |
The Vanderbilt ADHD rating Scales (VARS) [117] | 6-12 | • Parent rated • Teacher rated | No | Yes |
The Development and Well-being Assessment (DAWBA) [118] | 2-17 | • Teacher rated | No | No |
RATE [113] | 16-54 | • Patient-rated • Informant rated | No | Yes |
Conners’ Adult Rating Scales (CAARS) [119] | 18+ | • Patient-rated Informant rated | Yes | No |
Adult ADHD Self-report Rating Scale (ASRS) [120] | 18+ | • Patient-rated | No | Yes |
Clinical interviews | ||||
Assessment name [reference ID] | Age range (years) | Application | Free access | |
ADHD Child Evaluation (ACE) [121] | 5-16 | Administered to informant (parent, carer, family member) close to patient. Patient also typically invited to contribute. | Yes | |
The Development and Well-being Assessment (DAWBA) [118] | 5-17 | Administered separately to patient (if age 11-17 years) and parent/carer | No | |
Young DIVA-5 [122] | 5-17 | Administered to patient in the presence of a parent, carer or family member (where possible) | No | |
ACE+ [123] | 16+ | Ideally administered to patient in the presence of an informant | Yes | |
Conners’ Adult ADHD Diagnostic Interview for DSM-IVTM [124] | 18+ | Administered to patient | No | |
Diagnostic Interview of Adult ADHD (DIVA-5) [125] | Limits not specified | Administered to patient | No | |
Diagnostic Interview for ADHD in Adults with Intellectual Disability (DIVA-5 ID) [125] | Limits not specified | Administered to patient with intellectual disability in the presence of an informant/carer (where possible) | No | |